Manning & Napier Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Manning & Napier Group's BSX Position: Q1 2024 in Review
Manning & Napier Group reduced its Boston Scientific (BSX) stake by 14% in Q1 2024, selling an estimated $2.67M and leaving 258,118 shares worth $17.7M. The position accounts for 0.2% of the portfolio, ranked #93.
Manning & Napier Group first reported a position in BSX in Q2 2019 and has held it in 20 quarters since. The position peaked at $26M in Q2 2019. 1,227 funds tracked by Wall St. Rank hold BSX as of Q1 2024.
- Manning & Napier Group held 258,118 shares of Boston Scientific worth $17.7M as of Q1 2024.
- Manning & Napier Group sold 41,457 Boston Scientific shares in Q1 2024, an estimated $2.67M.
- Boston Scientific made up 0.2% of Manning & Napier Group's portfolio in Q1 2024, its #93 holding.
- Manning & Napier Group first reported a position in Boston Scientific in Q2 2019 and has held it in 20 quarters since.
- Manning & Napier Group's Boston Scientific position peaked at $26M in Q2 2019.
- 1,227 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.
Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.